CoChat

The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

Mirmasoumi, Golara, Fazilati, Mohammad, Foroozanfard, Fatemeh, Vahedpoor, Zahra, Mahmoodi, Samaneh, Taghizadeh, Mohsen, Esfeh, Nazanin Kazemi, Mohseni, Maryam, Karbassizadeh, Hassan, Asemi, Zatollah · 2018 · Experimental and Clinical Endocrinology & Diabetes
Cited by 64

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Objective This study was conducted to evaluate the effects of flaxseed oil omega-3 fatty acids supplementation on metabolic status of patients with polycystic ovary syndrome (PCOS). Methods This randomized double-blind, placebo-controlled trial was conducted on 60 women with PCOS according to the Rotterdam criteria aged 18–40 years old. Participants were randomly assigned into two groups to receive either 1,000 mg flaxseed oil omega-3 fatty acids (n=30) or placebo (n=30) twice a day for 12 weeks. Metabolic, endocrine, inflammatory factors were quantified at baseline and after the 12-week intervention. Results After the 12-week intervention, compared to the placebo, flaxseed oil omega-3 supplementation significantly decreased insulin values (−2.6±7.7 vs.+1.3±3.9 µIU/mL, P=0.01), homeostasis model of assessment-estimated insulin resistance (−0.7±1.7 vs.+0.3±0.9, P=0.01), mF-G scores (−1.2±1.7 vs. -0.1±0.4, P=0.001), and increased quantitative insulin sensitivity check index (+0.01±0.02 vs. −0.01±0.02, P=0.01). In addition, supplementation with flaxseed oil omega-3 resulted in significant decreases in serum triglycerides (−5.1±20.9 vs.+9.7±26.1 mg/dL, P=0.01), VLDL-cholesterol (−1.0±4.2 vs.+1.9±5.2 mg/dL, P=0.01) and high-sensitivity C-reactive protein (hs-CRP) (−1.6±3.1 vs.+0.2±1.5 mg/L, P=0.004) compared to the placebo. We did not see any significant effect of flaxseed oil omega-3 supplementation on hormonal and other lipid profiles, and plasma nitric oxide levels. Conclusions Overall, flaxseed oil omega-3 supplementation for 12 weeks in women with PCOS had beneficial effects on insulin metabolism, mF-G scores, serum triglycerides, VLDL-cholesterol and hs-CRP levels, but did not affect hormonal and other lipid profiles, and plasma nitric oxide levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0043-119751

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 32

  1. S Trikudanathan, 2015, Polycystic ovarian syndrome, Med Clin North Am, 99, 221, 10.1016/j.mcna.2014.09.003 · DOI
  2. S J Vagi, 2014, Exploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfluorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: a case-control study, BMC Endocr Disord, 14, 86, 10.1186/1472-6823-14-86 · DOI · Paper page
  3. B Pourghassem Gargari, 2015, Relationship between serum leptin, ghrelin and dietary macronutrients in women with polycystic ovary syndrome, Int J Fertil Steril, 9, 313
  4. D Macut, 2013, Dyslipidemia and oxidative stress in PCOS, Front Horm Res, 40, 51, 10.1159/000341683 · DOI · Paper page
  5. J Schmidt, 2014, Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women, Mol Hum Reprod, 20, 49, 10.1093/molehr/gat051 · DOI · Paper page
  6. A Jalilian, 2015, Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis, Iran J Reprod Med, 13, 591
  7. M Rafraf, 2012, Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome, J Am Coll Nutr, 31, 361, 10.1080/07315724.2012.10720443 · DOI · Paper page
  8. K Prasad, 2009, Flaxseed and cardiovascular health, J Cardiovasc Pharmacol, 54, 369, 10.1097/FJC.0b013e3181af04e5 · DOI · Paper page
  9. K Nasri, 2017, The effects of omega-3 fatty acids supplementation on gene expression involved in the insulin and lipid signaling pathway in patients with polycystic ovary syndrome, Horm Metab Res, 49, 446, 10.1055/s-0042-122782 · DOI
  10. S C Cunnane, 1995, Nutritional attributes of traditional flaxseed in healthy young adults, Am J Clin Nutr, 61, 62, 10.1093/ajcn/61.1.62 · DOI · Paper page
  11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
  12. G Oner, 2013, Efficacy of omega-3 in the treatment of polycystic ovary syndrome, J Obstet Gynaecol, 33, 289, 10.3109/01443615.2012.751365 · DOI · Paper page
  13. R Hatch, 1981, Hirsutism: implications, etiology, and management, Am J Obstet Gynecol, 140, 815, 10.1016/0002-9378(81)90746-8 · DOI · Paper page
  14. E Tatsch, 2011, de Campos MM, et al. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate, Clin Biochem, 44, 348, 10.1016/j.clinbiochem.2010.12.011 · DOI · Paper page
  15. B N Hyderali, 2015, Oxidative stress and cardiovascular complications in polycystic ovarian syndrome, Eur J Obstet Gynecol Reprod Biol, 191, 15, 10.1016/j.ejogrb.2015.05.005 · DOI
  16. H F Escobar-Morreale, 2011, Circulating inflammatory markers in polycystic ovary syndrome: A systematic review and metaanalysis, Fertil Steril, 95, 1048, 10.1016/j.fertnstert.2010.11.036 · DOI · Paper page
  17. E Mohammadi, 2012, Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome, Asia Pac J Clin Nutr, 21, 511
  18. S Navas-Carretero, 2009, An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women, Br J Nutr, 102, 546, 10.1017/S0007114509220794 · DOI · Paper page
  19. J Eritsland, 1994, Long-term effects of n-3 fatty acids on serum lipids and glycaemic control, Scand J Clin Lab Invest, 54, 273, 10.3109/00365519409087522 · DOI · Paper page
  20. Z Rasic-Milutinovic, 2007, Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients, Ren Fail, 29, 321, 10.1080/08860220601184092 · DOI · Paper page
  21. A Sadeghi, 2017, Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials, Diabetes Metab Syndr, 11, 157, 10.1016/j.dsx.2016.06.025 · DOI
  22. S Cassar, 2015, Biomarkers and insulin sensitivity in women with PCOS: Characteristics and predictive capacity, Clin Endocrinol (Oxf), 83, 50, 10.1111/cen.12619 · DOI · Paper page
  23. J Bellenger, 2011, High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: Inflammatory pathway inhibition, Diabetes, 60, 1090, 10.2337/db10-0901 · DOI · Paper page
  24. A J Cussons, 2009, Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: A randomized controlled trial employing proton magnetic resonance spectroscopy, J Clin Endocrinol Metab, 94, 3842, 10.1210/jc.2009-0870 · DOI · Paper page
  25. M L Vargas, 2011, Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome, Metabolism, 60, 1711, 10.1016/j.metabol.2011.04.007 · DOI · Paper page
  26. R Oh, 2005, Practical applications of fish oil (Omega-3 fatty acids) in primary care, J Am Board Fam Pract, 18, 28, 10.3122/jabfm.18.1.28 · DOI · Paper page
  27. H Fakhrzadeh, 2010, The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: A randomized controlled clinical trial, Int J Vitam Nutr Res, 80, 107, 10.1024/0300-9831/a000011 · DOI · Paper page
  28. K Qi, 2008, Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles, Clin Nutr, 27, 424, 10.1016/j.clnu.2008.02.001 · DOI
  29. P D Tsitouras, 2008, High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults, Horm Metab Res, 40, 199, 10.1055/s-2008-1046759 · DOI · Paper page
  30. H Li, 2005, EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-gamma-dependent mechanism, Kidney Int, 67, 867, 10.1111/j.1523-1755.2005.00151.x · DOI · Paper page
  31. A Rossi, 2000, Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase, Nature, 403, 103, 10.1038/47520 · DOI · Paper page
  32. D Wu, 2004, Effect of concomitant consumption of fish oil and vitamin E on production of inflammatory cytokines in healthy elderly humans, Ann N Y Acad Sci, 1031, 422, 10.1196/annals.1331.062 · DOI

Cited by

See all 64

Metadata

Authors
Mirmasoumi, G., Fazilati, M., Foroozanfard, F., Vahedpoor, Z., Mahmoodi, S., Taghizadeh, M., Esfeh, N. K., Mohseni, M., Karbassizadeh, H., & Asemi, Z.
Venue
Experimental and Clinical Endocrinology & Diabetes
Published
2017-11-08
Volume
126
Issue
04
Pages
222-228
ISSN
  • 0947-7349 (ISSN-L)
  • 1439-3646
OpenAlex
W2767285185
Cited by
64
References
7
FWCI
4.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.1055/s-0043-119751
The paper
Mirmasoumi, G., Fazilati, M., Foroozanfard, F., Vahedpoor, Z., Mahmoodi, S., Taghizadeh, M., Esfeh, N. K., Mohseni, M., Karbassizadeh, H., & Asemi, Z. (2018). The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Experimental and Clinical Endocrinology & Diabetes. https://doi.org/10.1055/s-0043-119751

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.